When cetuximab and PBR extract were combined, enhanced antitumor activity (as assessed by cell viability and clonogenic properties) in G12V KRAS mutant colon cancer cells was observed, which was caused by apoptosis. The gene discussed is KRAS; the disease is colonic neoplasm.